Founded with a mission to revolutionize animal health, Bactana Corp. is a global development stage company focused on leveraging microbial ecology to create safe, effective, and sustainable alternatives to antibiotics. Their innovative approach involves isolating molecules from naturally occurring anaerobic bacteria to treat metabolic conditions in pets and livestock, aiming to reduce the reliance on traditional antibiotic treatments and promote overall animal well-being.
Bactana has garnered attention from notable investors and industry experts who recognize the potential of their groundbreaking technology. The company's achievements include significant advancements in microbial-based treatments that have the potential to transform animal health practices worldwide. By providing sustainable solutions, Bactana is making a substantial impact on the industry, promoting healthier livestock and pets while addressing global concerns over antibiotic resistance.
